Opus Genetics (IRD) Current Taxes (2022 - 2023)

Opus Genetics (IRD) posted quarterly Current Taxes of $11000.0 for Q3 2023, down 96.51% quarter-over-quarter from $315000.0 in Q1 2023.

Opus Genetics (IRD) Current Taxes (2022 - 2023) Analysis & Trends

Opus Genetics (IRD) has reported Current Taxes for 2 consecutive years, with $11000.0 the latest figure, recorded in Q3 2023.

In Q3 2023, Current Taxes changed N/A year-over-year to $11000.0; the TTM figure through Sep 2023 stood at $11000.0 (changed N/A YoY), while the FY2022 annual figure was $315000.0, changed N/A from the prior year.
Current Taxes declined to $11000.0 in Q3 2023 per IRD's latest filing, from $315000.0 in the prior quarter.
Across five years, Current Taxes topped out at $315000.0 in Q4 2022 and bottomed at $11000.0 in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	49.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	76.32 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	59,089.99
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Opus Genetics	298.36 Mn	209.55 Mn	-	-

Download Data